The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F23%3A00130598" target="_blank" >RIV/00216224:14110/23:00130598 - isvavai.cz</a>
Výsledek na webu
<a href="https://journals.lww.com/jbisrir/Fulltext/2023/03000/The_revised_JBI_critical_appraisal_tool_for_the.5.aspx" target="_blank" >https://journals.lww.com/jbisrir/Fulltext/2023/03000/The_revised_JBI_critical_appraisal_tool_for_the.5.aspx</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.11124/JBIES-22-00430" target="_blank" >10.11124/JBIES-22-00430</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
Popis výsledku v původním jazyce
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Název v anglickém jazyce
The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
Popis výsledku anglicky
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30230 - Other clinical medicine subjects
Návaznosti výsledku
Projekt
<a href="/cs/project/LTC20031" target="_blank" >LTC20031: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
JBI Evidence Synthesis
ISSN
2689-8381
e-ISSN
2689-8381
Svazek periodika
21
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
13
Strana od-do
494-506
Kód UT WoS článku
000945987900005
EID výsledku v databázi Scopus
2-s2.0-85150000433